How does lebrikizumab fit into proactive vs reactive AD treatment approaches?
Featuring Alexandra Golant, MD |
Medical Director, Dermatology Faculty Practice
Associate Director, Residency Program
Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY
Related Media
Powered by Polaris TM